Methotrexate (INN)
Methotrexate (INN) is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties

Methotrexate
Methotrexate is a member of pteridines, a monocarboxylic acid amide and a dicarboxylic acid. It has a role as an antimetabolite, an antineoplastic agent, an immunosuppressive agent, an antirheumatic drug, a dermatologic drug, an EC 1.5.1.3 (dihydrofolate reductase) inhibitor, an abortifacient and a DNA synthesis inhibitor. It is functionally related to a L-glutamic acid. It is a conjugate acid of a methotrexate(1-). — ChEBI
- IUPAC name
- (2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid
- Molecular formula
- C20H22N8O5
- Molecular weight
- 454.4 g/mol
- Exact mass
- 454.17131583 Da
- XLogP3
- -1.8
- Topological polar surface area
- 211.0 Ų
- Hydrogen-bond donors
- 5
- Hydrogen-bond acceptors
- 12
- Covalent units
- 1
- Defined stereocentres
- 1
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:44185
- ChEMBL:CHEMBL34259
- EPA DTXSID:DTXSID4020822
- PubMed:32020584
- PubMed:30415610
- PubMed:29268019
- PubMed:28117352
- PubMed:27379764
- PubMed:27210722
- PubMed:24284432
- PubMed:23895801
- PubMed:22968027
- PubMed:22702814
- PubMed:22639782
- PubMed:22587841
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Methotrexate (INN)
Regulatory information
Key data
Inventory links for Methotrexate (INN)
Related records for Methotrexate (INN)
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid (Tiratricol (INN)) and its salts
Aminocaproic acid (INN) and its salts
Cinchophen (INN), its salts, derivatives and salts of these derivatives
(2-Acetoxyethyl)trimethylammonium hydroxide (Acetylcholine) and its salts
Aconitum napellus L. (leaves, roots and galenical preparations)
Aconitine (principal alkaloid of Aconitum napellus L.) and its salts
Adonis vernalis L. and its preparations
What Annex II means for Methotrexate (INN)
Methotrexate (INN) is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
This record is linked to 2 CosIng inventory ingredients for name and identifier cross-reference. The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Methotrexate (INN)
This page summarizes one Annex II record for Methotrexate (INN) from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Methotrexate (INN), but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Methotrexate (INN) and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Methotrexate (INN) side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II